Source: Getty Images Despite proven benefits, biomarker tests remain underused in clinical practice. By examining genetic markers from urine or tissue samples, biomarkers provide a more precise ...

G_genetic testing New recommendations from an international consensus conference call for genetic testing of all men with metastatic prostate cancer (PCa) and those with a family history indicative of ...

Urologists had championed the prostate cancer test in the past It%27s a %22radical change%22 but a welcome one Risks of incontinence%2C impotence and infection are weighed In a major break from the ...

Clinical practice guidelines do not recommend routine PSA screening in men older than 75 years, men younger than 40 years, or men with a life expectancy of <10 years; however, inappropriate PSA ...

MDxHealth has 4 validated testing products with one more in the clinical pipeline. All are focused specifically on urology. The company expects to do ~$65-$70M of sales in 2023, but the valuation is a ...

P4 Diagnostix has teamed with Pierian, a company that provides an analysis platform, to launch somatic testing for patients with prostate cancer. The partnership will further develop P4 Diagnostix’s ...

BOSTON--(BUSINESS WIRE)--Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, and Solaris Health, the nation’s leading ...

In their recent study, Kerfoot and colleagues suggest that “prostatempathy”—the empathy felt by older male healthcare providers—could explain the significant association between inappropriate PSA ...

PRESS RELEASE: 3 December 2018, 22:30 CET/16:30 EST Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX Genomic Prostate Score ® Test REDWOOD ...